PAREXEL RECIST 1.1

Parexel Meeting Services

Study Reminder+

PAREXEL HORIZONS

Study Reminder +

Global Leadership Sales Summit

ClinPhone® RTSM

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Amazon

Content Delivery Network

LetsEncrypt

Company Owner

Adrian MacGrath

Medical Director at Parexel | Board-Certified Dermatologist

Alison Lyke

Assistant General Counsel

Amanda Vendig (Kirouac)

SVP, CFO - Consulting & Commercial

Amy France

Chief Medical Officer and Global Head, Oncology Center of Excellence

Amy Mckee

Vice President and Assistant General Counsel

Andrea Testa

Principal Statistical Programmer

Anthony McCarthy

Owner

Aubrey McMillon

Bertrand 32/476.33.32.39

Senior Director

Christie Wilkins

Jo Natauri

Patrick J. Fortune

Pat Fortune

Eduard E. Holdener

Amy Kirk

Director, University Relations- Talent Aquisition

Peyton Howell

Chief Operating & Growth Officer

Jon Wilkinson

Technology Privacy Officer

Gregory Rush

Executive Vice President and Chief Financial Officer

Magda Andritoiu

Senior Manager, Regulatory Affairs

Chief Executive Officer

Joe Avellone, MD

Senior Vice President, Clinical Research

Mike D'Ambrosio

SVP and Global Head Real World Research

Greater Boston Area Companies With More Than 50 Employees

Biotechnology Companies With More Than $500 in Revenue

Web Development Companies (Top 10K)

Northeastern US Companies With More Than 100 Employees (Top 10K)

PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. 

The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. This segment manages various aspects of clinical trials, including study and protocol design, case report form design, paper or electronic questionnaires design, patient enrollment, study monitoring and data collection, data analysis, report writing, and medical services. 

The PCMS segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, and good manufacturing practice compliance consulting; and market development, product development, and targeted communications services in support of product launch. Its consultants also identify alternatives and propose solutions to address clients product development, registration, and commercialization issues. In addition, this segment provides reimbursement and market access services. 

The Perceptive segment provides information technology solutions comprising medical imaging and systems integration services; ClinPhone RTSM, CTMS, and DataLabs EDC products; Web-based portals; and patient diary applications. 

The company was founded in 1983 and is headquartered in Waltham, Massachusetts.

Venture Round - PAREXEL

Advertising, Business and Retail Services

Waltham

Massachusetts

United States

North America

PAREXEL

Parexel Names Keri Mattox Chief Business Officer

Parexel Earns Prestigious Society for Clinical Research S...

Parexel powers up real-world research capabilities with new senior vice president

Firm grows local presence with $10M upgrade to drug testing facility

Contract Research Organization (CRO) Market to Witness Phenomenal Growth | Quintiles, PPD, Parexel, ICON

Clinical Trial Services Industry [SWOT Analysis]| PAREXEL International Corporation, IQVIA, Charles River Laboratory

Parexel and Palantir Expand Collaboration to Accelerate Clinical Data Delivery and Power Clinical Outcomes for Patients

Parexel partners with Palantir to boost clinical trials with AI

Parexel strikes deal with Palantir for clinical trial AI

Parexel strikes multi-year deal with Palantir for clinical trial AI

India

Asia

United Kingdom

Europe

Canada

Germany

HTML5

Apache Server

Vimeo

Google Maps API

GlobalSign

Google Analytics

Adobe Flash

Facebook Comments

Google Fonts

Fonts.com

Parexel is a global clinical research organization that designs and conducts clinical trials for pharmaceutical and biotechnology companies. They focus on patient-centric approaches to accelerate the development of innovative treatments, including cell and gene therapies.

Parexel

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 21, 2024 11:50 PM	b4d86e4d
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 21, 2024 11:50 PM	1b40f050
company summary	general
signals	general
crunchbase trigger	general	Nov 4, 2024 10:53 AM	adce72a0
crunchbase profile	general	Nov 4, 2024 11:21 AM	727adf85
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	bcc77274
peers	general
news basic	general	Mar 21, 2024 11:50 PM	d2c20e65
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PARE

COM:PAREXEL

Parexel